XML 163 R143.htm IDEA: XBRL DOCUMENT v3.20.4
Parent Company Financial Statements (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:                      
Net income $ 18,566 $ 18,322 $ 21,040 $ 11,901 $ 15,536 $ 18,814 $ 17,273 $ 17,495 $ 69,829 $ 69,118 $ 68,432
Adjustments to reconcile net income to net cash provided by operating activities:                      
(Increase) decrease in other assets                 (57,730) (27,961) (7,456)
Change in fair value of contingent consideration liability                 0 0 (187)
Tax (expense) benefit from stock option exercises and other equity awards                 (103) 248 496
Net cash provided by (used in) operating activities                 36,478 73,435 82,876
Cash flows from investing activities:                      
Net cash provided by (used in) investing activities                 (264,240) (160,115) (481,831)
Cash flows from financing activities:                      
Payment of contingent consideration liability                 0 0 (1,217)
Treasury stock purchased                 (4,322) 0 0
Net proceeds from stock option exercises and issuance of other equity awards, net of awards surrendered                 (470) 273 (671)
Cash dividends paid                 (35,499) (34,189) (29,312)
Net cash provided by (used in) financing activities                 291,575 131,660 409,507
Cash and cash equivalents at beginning of year       138,455       93,475 138,455 93,475 82,923
Cash and cash equivalents at end of year 202,268       138,455       202,268 138,455 93,475
Parent Company [Member]                      
Cash flows from operating activities:                      
Net income                 69,829 69,118 68,432
Adjustments to reconcile net income to net cash provided by operating activities:                      
(Increase) decrease in dividend receivable                 (2,261) (1,813) 8
(Increase) decrease in other assets                 109 (43) 70
Increase (decrease) in accrued expenses and other liabilities                 (31) (15) 17
Change in fair value of contingent consideration liability                 0 0 (187)
Tax (expense) benefit from stock option exercises and other equity awards                 (103) 248 496
Other, net                 193 (195) (465)
Net cash provided by (used in) operating activities                 40,111 33,842 31,448
Cash flows from financing activities:                      
Payment of contingent consideration liability                 0 0 (1,217)
Treasury stock purchased                 (4,322) 0 0
Net proceeds from stock option exercises and issuance of other equity awards, net of awards surrendered                 (470) 273 (671)
Cash dividends paid                 (35,499) (34,189) (29,312)
Net cash provided by (used in) financing activities                 (40,291) (33,916) (31,200)
Net increase (decrease) in cash and cash equivalents                 (180) (74) 248
Cash and cash equivalents at beginning of year       $ 1,838       $ 1,912 1,838 1,912 1,664
Cash and cash equivalents at end of year $ 1,658       $ 1,838       1,658 1,838 1,912
Bank [Member]                      
Adjustments to reconcile net income to net cash provided by operating activities:                      
Equity in undistributed earnings (losses) of subsidiaries                 (27,603) (33,445) (36,876)
Non-bank [Member]                      
Adjustments to reconcile net income to net cash provided by operating activities:                      
Equity in undistributed earnings (losses) of subsidiaries                 $ (22) $ (13) $ (47)